A multi-million-pound investment project is to deliver an innovation hub to double the number of life sciences companies in the north-east.
The Bio-therapeutics Hub for Innovation in Aberdeen has received a £40 million investment.
It has secured £20m capital funding from the UK and Scottish governments through the Aberdeen City Region Deal.
The project has been developed by the ONE Life Sciences sector board, Aberdeen University, Robert Gordon University, NHS Grampian and Scottish Enterprise.
The hub will be located on the Foresterhill Health Campus.
Professor Stephen Logan, chairman of the ONE Life Sciences sector board, said: “This is a transformational project of national significance that supports the regional economic goal of diversification and will contribute to national ambitions for life sciences as a driver for health and wealth.”